I can hardly share the passionate enthusiasm of Breuhahn et al. for the ''dramatic'' improvements in understanding of molecular pathogenesis of hepatocellular carcinoma (HCC) and the claim for ''further rationally designed clinical trials based on molecular evidence''. 1 Among the causes of HCC, the
β¦ LIBER β¦
Promising Therapeutic Targets in Neuroblastoma
β Scribed by Matthay, K. K.; George, R. E.; Yu, A. L.
- Book ID
- 111685568
- Publisher
- American Association for Cancer Research
- Year
- 2012
- Tongue
- English
- Weight
- 843 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1078-0432
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis C virus therapeutics: Editing
β
Anna Alisi; Sara Tomaselli; Clara Balsano; Angela Gallo
π
Article
π
2011
π
John Wiley and Sons
π
English
β 320 KB
Phospholamban: A Promising Therapeutic T
β
Albrecht G. Schmidt; Istvan Edes; Evangelia G. Kranias
π
Article
π
2001
π
Springer US
π
English
β 437 KB
Activating mutations in ALK provide a th
β
George, Rani E.; Sanda, Takaomi; Hanna, Megan; FrΓΆhling, Stefan; II, William Lut
π
Article
π
2008
π
Nature Publishing Group
π
English
β 379 KB
XIAP: Apoptotic brake and promising ther
β
Martin Holcik; Hilary Gibson; Robert G. Korneluk
π
Article
π
2001
π
Springer
π
English
β 558 KB
New therapeutic targets for the treatmen
β
Lars M. Wagner; Mary K. Danks
π
Article
π
2009
π
John Wiley and Sons
π
English
β 146 KB
## Abstract Highβrisk neuroblastoma remains a major problem in pediatric oncology, accounting for 15% of childhood cancer deaths. Although incremental improvements in outcome have been achieved with the intensification of conventional chemotherapy agents and the addition of 13β__cis__βretinoic acid
Angiogenesis: A promising therapeutic ta
β
A. Bamias; S. Pignata; E. Pujade-Lauraine
π
Article
π
2012
π
Elsevier Science
π
English
β 519 KB